July 27, 2012
Takeda Pharmaceutical and its US subsidiary Millennium Pharmaceuticals announced on July 26 that Takeda Bio Development Center Limited initiated a PIII clinical trial in July in Japan, Hong Kong, South Korea, and Taiwan to evaluate AMG706 (motesanib) in combination with...read more